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Abstract
Background: Hospital readmission has attracted attention from policymakers as a measure of quality
and a target for cost reduction. The aim of the study was to evaluate the frequency and patterns of
rehospitalization after a pancreaticoduodenectomy (PD).
Methods: The records of all patients undergoing a PD at an academic medical centre for malignant
or benign diagnoses between January 2006 and September 2011 were retrospectively reviewed. The
incidence, aetiology and predictors of subsequent readmission(s) were analysed.
Results: Of 257 consecutive patients who underwent a PD, 50 (19.7%) were readmitted within 30 days
from discharge. Both the presence of any post-operative complication (P = 0.049) and discharge to
a nursing/rehabilitation facility or to home with health care services (P = 0.018) were associated with
readmission. The most common reasons for readmission were diet intolerance (36.0%), pancreatic
fistula/abscess (26.0%) and superficial wound infection (8.0%). Nine (18.0%) readmissions had lengths of
stay of 2 days or less and in four of those (8.0%) diagnostic evaluation was eventually negative.
Conclusion: Approximately one-fifth of patients require hospital readmission within 30 days of dis-
charge after a PD. A small fraction of these readmissions are short (2 days or less) and may be preventable
or manageable in the outpatient setting.
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Introduction
The Affordable Care Act (ACA) of 2010 set the foundation for a
number of new quality measures for the health care system. Begin-
ning as early as October of 2012, Medicare reimbursements will
likely be decreased for 30-day hospital readmissions above a speci-
fied observed-to-expected ratio for acute myocardial infarction
(AMI), heart failure and pneumonia.1 It is anticipated that the list
of conditions to which these rules are applied will expand in the
coming years. Complex abdominal surgery is of particular interest
for cost savings given high rates of post-operative morbidity and
readmission.
Pancreaticoduodenectomy (PD) has been the focus of read-
mission studies given post-operative morbidity rates of 40–60%
and 30-day readmission rates ranging from 16–22% (Table 1).2–8
Readmission after a PD is commonly associated with a number
of procedure-specific complications as well as with general post-
operative complications and disease progression.While the debate
continues regarding whether any of these readmissions are truly
preventable, it is clear that there is an associated economic burden.
A recent study by Kent et al. found an approximate increase in
mean overall medical cost of $16 000 per patient readmitted after
a PD ($41 000) relative to their non-readmitted counterparts
($25 000).2
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With emerging political measures aimed at limiting the cost
and improving the quality of the health care services provided in
the United States, it will become increasingly important for prac-
titioners to stay engaged, along with payers and hospital admin-
istrators, in defining expected disease- and procedure-specific
outcomes.While decreasing readmission rates will benefit patients
as well as the health care system, it is prudent to prevent the
necessary readmission from being perceived as a ‘failed discharge’,
but rather as a an ‘early rescue’.9 The current study aimed to
further define the incidence, aetiology and characteristics of
readmissions after a PD by evaluating a contemporary cohort
of patients at a high-volume pancreatic surgery centre.
Methods
After obtaining institutional review board approval, the medical
records of all patients undergoing a PD between January 2006 and
September 2011 at our tertiary referral academic medical centre
were retrospectively reviewed. Data were collected from the index
hospitalization as well as all subsequent readmissions within 12
months of the index discharge. The time to readmission was
defined using the day of index discharge as the day of reference.
Readmissions to outside hospitals were not captured.
Individual patient data collection included basic demographics,
pre-operative factors [diabetes mellitus (DM), coronary artery
disease (CAD), hypertension (HTN), and tobacco use], intra-
operative factors (estimated blood loss, major vascular recon-
struction and pylorus preservation), postoperative outcomes and
hospital length of stay (LOS).
Post-operative outcomes were identified by review of discharge
International Classification of Diseases, 9th Revision (ICD-9) codes
and by individual review of the medical record. Patients were
considered to have a pancreatic fistula if they met a minimum
of the criteria required for the diagnosis of a grade A fistula as
defined by the International Study Group of Pancreatic Fistula
(>3¥ normal serum amylase with no clinical manifestation).10
It should be noted, however, that drain fluid amylase was not
routinely checked thus preventing the identification of some
non-clinically relevant pancreatic fistulae. Similarly, the diagnosis
of delayed gastric emptying (DGE) was applied to any patient who
met at least the minimum criteria required for the diagnosis
of grade A DGE as defined by the International Study Group
of Pancreatic Surgery (one of the following: nasogastric tube
required for more than 3 days, NGT reinserted after post-
operative day three or inability to tolerate solid oral intake by
post-operative day seven).11 A surgical site infection (SSI) was
defined according to the commonly accepted Center of Disease
Control (CDC) classification scheme.12
The post-operative care of the patients included in this study
was left to the discretion of the attending surgeon in conjunction
with the house staff. No fast-track programmes or post-operative
pathways were instituted during the study period.
Readmission diagnoses were identified by ICD-9 codes and
were confirmed by review of the associated admission note,
daily progress notes and discharge summary. For the purpose of
analysis, diagnoses were grouped into the following categories:
procedure-related complications, general post-operative com-
plications, readmission for diagnostic workup and others.
The ‘procedure-related’ category included a pancreatic fistula,
abdominal abscess/phlegmon, haemorrhage, cholangitis and per
os (PO) intolerance. The ‘general post-operative’ category
included SSI, urinary tract infection (UTI), deep venous throm-
bosis (DVT) and bacteraemia. The ‘negative diagnostic workup’
category included those patients readmitted with symptoms for
whom no underlying diagnosis was identified after detailed
evaluation. The ‘other’ category included admission for chest
Table 1 Previous studies on incidence and predictors of readmission after a major pancreatic surgery
Author Year Study
period
Type PD (n) Readmission with
30 days from
discharge
Predictors of
readmission
Not predictors
of readmission
Grewal et al.15 2011 2005–2010 Single-
institution
124 18.5%a LOS, chronic pancreatitis,
transfusion
Commorbidities,
complications, biliary
stent, BMI, pylorus
preservation, vascular
reconstruction
Kent et al.2 2011 2001–2009 Single-
institution
371 22% Small duct (<3 mm), any/major
complications, clinical or
latent pancreatic fistula,
DGE, SSI
Age, gender, BMI, ASA,
POSSUM, malignancy,
blood loss, transfusion
Reddy et al.8 2009 1992–2003 SEER 1309 16% LOS > 10 days, distal
pancreatectomy
Demographics,
complications
Yermilov et al.4 2009 1994–2003 OSHPD 2023 19% LOS, age >73 yrs, T-stage,
comorbidity
Gender, race, nodal status
aWithin 30–90 days after surgery.
ASA, American Society of Anesthesiologists Physical Status classification system; BMI, body mass index; DGE, delayed gastric emptying; EBL,
estimated blood loss; LOS, length of stay; OSHPD, Office of Statewide Health Planning and Development database; PD, pancreaticoduodenectomy;
POSSUM, Physiological and Operative Severity Score for the enumeration of Mortality and Morbidity predictor of risk; SEER, Surveillance Epidemi-
ology and End Results database; SSI, surgical site infection.
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pain, ketoacidosis, dehydration, constipation and unrelated
procedures.
Statistical analyses
Statistical analyses were performed using SAS statistical software
(SAS Enterprise Guide 4.3; SAS Institute Inc., Cary, NC, USA).
Demographic, pre-operative, intra-operative and post-operative
factors were evaluated as predictors of readmission in univariate
analyses. Student’s t-test and chi-square were used to analyse con-
tinuous and categorical outcomes, respectively. A multivariate
logistic regression was performed using factors of significance
from the univariate analyses while controlling for patient age,
gender, pre-operative comorbidities and disease pathology.
Survival analysis was performed using non-parametric Kaplan–
Meier methodology. All outcomes were considered statistically
significant when P < 0.05.
Results
Two hundred fifty-seven (257) patients underwent a PD at
our institution between January 2006 and September 2011.
In-hospital mortality was 1.9% (n = 5, Fig. 1). Readmission rates
were 19.7% (50/254) within 30 days, 24.0% (59/246) within 90
days, 27.4% (63/230) within 6 months and 37.4% (73/195) within
1 year from index discharge. The number of patients decreased as
those who died were excluded and not all patients in the cohort
had reached the indicated length of follow-up at the time of analy-
sis. Twenty-three (8.9%) patients required multiple readmis-
sions. There was no statistical difference in age, gender, pre- or
intra-operative factors between patients requiring readmission
within 30 days from index discharge and their non-readmitted
counterparts (Table 2).
The post-operative complications identified during index hos-
pitalization included delayed gastric emptying (n = 73, 28.4%),
pancreatic fistula (n = 40, 15.6%), surgical site infection (n = 23,
8.9%), urinary tract infection (n = 17, 6.6%), abdominal abscess
(n = 12, 4.7%) and hemorrhage (n = 8, 3.1%) with 18 additional
complications occurring in less than 3% of the study population
(Fig. 1). One hundred fifty-nine patients (61.9%) experienced at
least one post-operative complication.
Those not readmitted were less likely to have experienced a
post-operative complication relative to their readmitted counter-
parts (58.9% versus 74%, P = 0.049). Readmitted patients experi-
enced relatively higher rates of pancreatic fistulae, delayed gastric
emptying and surgical site infections, but these trends failed to
reach statistical significance (Table 3). In multivariate logistic
regression controlling for patient age, gender, pre-operative
comorbidities and disease pathology, the presence of any post-
operative complication was associated with readmission with an
odd ratio (OR) of 2.02 [95% confidence interval (CI) 1.02–4.21]
(Table 4).
Figure 1 Post-operative complications during index hospitalization (% of all operations, n = 257). *Post-operative deaths: 3 deaths within 30
days of operation, 2 additional deaths during index hospitalization >30 days after operation (1.2% 30-day mortality, 1.9% in-hospital
mortality). **Other (n = 1 for each complication noted): cerebral vascular accident, deep vein thrombosis, portal vein thrombus, pulmonary
embolus, pseudoaneurysm without haemorrhage, biliary obstruction, bowel necrosis, decubitus ulcer, sepsis from indeterminate source and
a complication from an unrelated procedure. DGE, delayed gastric emptying; SSI, surgical site infection; MI, myocardial infarction
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The level of care required at index discharge was associated with
readmission. After routine discharge to home, patients had lower
rates of 30-day readmission compared with patients discharged
with home health services and as well as those discharged to
nursing/rehabilitation facilities (16.7%, 34.8%, 36.8%, P = 0.018;
Table 3). Multivariate logistic regression controlling for patient
age, gender, pre-operative comorbidities and disease pathology,
subsequently found non-routine discharge (discharge with home
health services or discharge to nursing or rehab facility) to be
associated with 30-day readmission with an OR of 2.69 (95% CI
1.17–6.12) (Table 4).
The median LOS for index admission was 11.0 days in both the
readmitted and non-readmitted groups with the mean LOS 18.0
versus 14.4 days, respectively (P = 0.066; Table 3). The mean
cumulative LOS (i.e. the summed LOS of index readmission and
all subsequent readmissions within 1 year of index discharge)
was, not surprisingly, significantly longer for patients requiring
readmission within 30 days of index discharge (30.3 versus 15.9
days, P < 0.0001; Table 3).
Indications for readmission included procedure-related com-
plications (n = 33, 66.0%), general post-operative complications
(n = 7, 14.0%), negative fever workup (n = 4, 8.0%) and other
(n = 6, 12.0%) (Table 5).
Table 2 Patient characteristics stratified by 30-day readmission
Characteristic No readmission (n = 207) Readmission (n = 50) P
Pre-operative factors
Age, years, mean (SD) 64.4 (11.3) 65.3 (13.7) 0.633
Female, n (%) 83 (40.1) 24 (48.0) 0.309
Hypertension, n (%) 94 (45.4) 21 (43.9) 0.747
Coronary artery disease, n (%) 31 (14.9) 3 (6.1) 0.101
Diabetes, n (%) 50 (24.2) 10 (20.4) 0.578
Current tobacco use, n (%) 28 (13.5) 4 (8.0) 0.303
Intra-operative factors
Estimated blood loss > 500 ml, n (%) 112 (54.1) 28 (56.0) 0.830
Vessel reconstruction, n (%) 22 (10.6) 2 (4.0) 0.148
Pylorus preservation, n (%) 160 (77.3) 36 (72.0) 0.430
Pathology
Malignant, n (%) 157 (75.9) 35 (70.0) 0.393
Table 3 Factors associated with 30-day readmission
No Readmission (n = 207) Readmission (n = 50) P
Any complication, n (column %) 122 (58.9) 37 (74.0) 0.049
Pancreatic fistula, n (column %) 30 (14.5) 10 (20.0) 0.335
Delayed gastric emptying, n (column %) 57 (27.5) 17 (34.0) 0.365
Surgical site infection, n (column %) 16 (7.7) 7 (14.0) 0.163
Other complicationa, n (column %) 55 (26.6) 19 (38.0) 0.119
Disposition
Home, n (row %) 175 (83.3) 35 (16.7) 0.018
Home health care services, n (row %) 15 (65.2) 8 (34.8)
Nursing/rehabilitation facilityx, n (row %) 12 (63.2) 7 (36.8)
Index Hospitalization LOSa, mean (median, range) 14.4 (11.0, 6–116) 18.0 (11.0, 7–92) 0.066
Cumulative LOS, mean (median, range) 15.9 (11.0, 6–122) 30.3 (26.0, 8–153) <0.001
aOther: urinary tract infection (UTI), abscess, haemorrhage, pneumonia, myocardial infarction (MI), respiratory distress, dysrhythmia, death, colitis,
bile leak, chyle leak, cerebral vascular accident, deep vein thrombosis, portal vein thrombus, pulmonary embolus, pseudoaneurysm without
haemorrhage, biliary obstruction, bowel necrosis, decubitus ulcer, sepsis from indeterminate source and a complication from an unrelated procedure.
Table 4 Multivariate logistic regression for predictors of 30-day
readmissiona
Odds
ratio
95% Confidence
Interval
Any post-operative complication 2.02 1.02–4.21
Non-routine discharge 2.69 1.17–6.12
aControlled for age, gender, coronary artery disease (CAD), diabetes
mellitus (DM), hypertension (HTN), tobacco use, malignant disease.
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The median LOS for the readmissions was 6 days (range 1–32).
Of 50 patients readmitted within 30 days, 9 (18.0%) had a
readmission LOS of 1 to 2 days. Indications for these readmis-
sions included fever with a negative workup (n = 3), an UTI (n =
1), cholangitis (n = 1), SSI (n = 1), PO intolerance (n = 1), chest
pain with a negative workup (n = 1) and an unrelated procedure
(n = 1) (Table 6). Therefore, 4 out of 9 patients readmitted for
just 1 to 2 days were readmitted for diagnostic evaluation
of symptoms (fever and chest pain) without identification of a
specific diagnosis.
Kaplan–Meier survival analysis revealed no discernible differ-
ence in survival for those readmitted relative to the non-
readmitted cohort (Fig. 2, Table 7). This held true for patients
with both benign and malignant disease.
Discussion
In the current study, 19.7% of all patients undergoing a PD were
readmitted within 30 days of index discharge. Readmission was
associated with the occurrence of any post-operative complication
and with the level of care required at discharge. Readmitted
patients had a longer mean index LOS relative to their non-
readmitted counterparts, although this trend failed to reach sta-
tistical significance (18.0 versus 14.4 days, P = 0.066). Nine
patients (18.0% of the readmitted patients) had readmission LOS
of 1–2 days, four (8.0%) of whomwere ultimately discharged after
a negative diagnostic workup. There was no difference in survival
between the readmitted and non-readmitted patients during the
study period.
The findings of the present study are consistent with the reports
by Emick et al. (2006) and Kent et al. (2011) both of whom found
readmission after a PD to be associated with post-operative com-
plications during the index hospitalization.2,13 In the current
study, 80% of all readmissions were for indications related to
the operation (66% procedure specific and 14% general post-
operative) compared with 65% in the Kent et al. study (47% pro-
cedure specific and 18% general post-operative).2 Also congruent
with the existing literature was the trend towards a longer index
LOS for the patients requiring readmission. Emick et al. reported
an increase in the mean index LOS for readmitted patients (13.8
versus 11.6 days, P = 0.02), an observation confirmed in two large
administrative database reviews, suggesting that the shorter index
hospitalization, or premature discharge, is not primarily respon-
sible for readmission after a PD (Table 1).3,4,13
Our observation of a higher rate of readmission in patients
discharged with home health services and those discharged to
skilled nursing/rehab facilities is consistent with two previous
reports.2,14 Specifically, in a prospective study of 266 patients
undergoing major intra-abdominal procedures (including
oesophageal, gastric, intestinal, liver and pancreatic resections),
Martin et al. reported a 27% rate of readmission within 90 days
from the index operation.14 Among the 72 patients who were
readmitted, 62% were discharged with home health services and
19% to subacute rehabilitation as opposed to only 11% and 10%
of their non-readmitted counterparts (P < 0.0001).14 In addition,
only 25% of patients who got readmitted were seen by the treating
physician before the readmission.14 These findings may certainly
suggest that discharge resources are being appropriately allocated
to sicker patients (i.e. those more likely to be readmitted).
Table 5 Primary diagnosis at 30-day readmission
n (%)
Procedure-cpecific complication 33 (66.0)
PO intolerance 18 (36.0)
Pancreatic fistula/abscess/phlegmon 13 (26.0)
Haemorrhage 1 (2.0)
Cholangitis 1 (2.0)
General post-operative complications 7 (14.0)
SSI 4 (8.0)
UTI 1 (2.0)
DVT 1 (2.0)
Bacteraemia 1 (2.0)
Negative fever workup 4 (8.0)
Othera 6 (12.0)
aOther: Negative workup for chest pain, ketoacidosis, dehydration,
constipation, liver failure, unrelated procedure.
UTI, urinary tract infection; SSI, surgical site infection; DVT, deep vein
thrombosis.
Table 6 Characteristics of readmissions with length of stay (LOS)
1–2 days (n = 9)
Patient Readmission
LOS (d)
Time from index
discharge to
readmission (days)
Readmission
Dx
1 1 8 Fevera
2 2 10 Fevera
3 2 23 Fevera
4 2 2 UTI
5 2 8 SSI
6 2 29 Cholangitis
7 1 8 PO intolerance
8 1 11 Chest paina
9 2 18 Unrelated procedure
aNegative diagnostic workup.
UTI, urinary tract infection; SSI, surgical site infection; PO, per os.
Table 7 Kaplan–Meier survival curves, number at risk
Month
0
Month
20
Month
40
Month
60
Benign, readmitted 15 5 4 1
Benign, not readmitted 50 30 18 1
Malignant, readmitted 35 20 8 1
Malignant, not readmitted 157 49 16 5
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However, closer communication with the next level of caregivers
and more intensified outpatient follow-up appear reasonable
strategies for the timely identification and management of post-
operative problems that may eventually lead to rehospitalization.
Of all 30-day readmissions in the present study, 18.0% (9/50)
had a LOS of 2 days or less. Four of these patients (8.0% of all
readmissions) underwent a negative diagnostic workup and were
discharged without intervention. Kent et al. reported that of all
patients readmitted after a major pancreatic resection, 14%
presented with some element of clinical concern, but inpatient
diagnostic evaluation failed to identify a specific diagnosis or
complication.2 Perhaps this small fraction of readmitted patients
could be evaluated in the outpatient setting or in a 23-h observa-
tional unit and then rehospitalized if diagnostic evaluation points
to a specific diagnosis mandating inpatient care. This approach
may prevent this small fraction (8–14%) of readmissions after
a PD.
The present study has a number of limitations worthy of dis-
cussion. The single institution design may limit the generalizabil-
ity of the results. Additionally, the present study did not capture
readmissions to outside hospitals and may have underestimated
the actual rate of rehospitalization after a PD. Interestingly,
however, two recent administrative database analyses of patients
undergoing a PD (capturing readmission data to any hospital)
reported 30-day readmission rates of 16% and 19%.3,4 These data,
when compared with both the present study (19.7% 30-day
readmission rate) and the single-institution study performed by
Kent et al. (22.1% 30-day readmission rate for PD patients)
suggest that the majority of readmissions within 30 days of index
discharge occur at the index hospital and that little 30-day
readmission data are missed by single-institution studies.2 Finally,
the low number (n = 9) of patients who were readmitted for only
1–2 days limit the ability to draw definitive conclusions regarding
the preventability of such ‘short’ readmissions.
It is undeniable that hospital readmission is a burden on the
health care system. A recent analysis of 11.8 million hospitalized
Medicare beneficiaries found an overall 30-day readmission rate
of roughly 20% (medical and surgical patients) at an annual cost
of $17.4 billion.15 When the focus is major abdominal surgery,
however, the issue of readmission as a quality metric is complex.
In a recent editorial, Brown et al. put forth the notion that
readmission of the post-surgical patient may lead to the early
detection and ‘rescue’ of a peri-operative complication in the
setting of good clinical judgment rather than represent a ‘failed
discharge’.9
Moving forward, it is important for surgeons to stay engaged in
policy discussions to ensure that novel quality metrics address the
issues as they pertain to surgical patients. In the case of complex
abdominal operations, such as a PD, the safest and most effective
patient care may require a relatively low threshold for readmis-
sion. Clearly, coordination of care is imperative particularly with
patients at a risk for re-admission. In patients with complications
and the need for extended care post-discharge, a greater emphasis
on post-discharge instruction and care could be brought forward.
While it is probably true that a small fraction of readmissions after
a PDmay be preventable, wemust approach this matter cautiously
to avoid stigmatization of the necessary readmission. We as
surgeons should at the very least participate in the discussion as
public policy is developed in this area.
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(a) Kaplan–meier curve, benign disease (b) Kaplan–meier curve, malignant disease
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Figure 2 Kaplan–Meier survival curves: (a) Patients with benign disease, show no difference in survival when stratified by 30-day readmission
(Log-Rank Chi-Square = 0.02, P = 0.88); (b) patients with malignant disease, show no difference in survival when stratified by 30-day
readmission (Log-Rank chi-square = 1.51, P = 0.22)
HPB 147
HPB 2013, 15, 142–148 © 2012 International Hepato-Pancreato-Biliary Association
References
1. Affordable Care Act. Available at http://www.healthcare.gov/law/full/ (last
accessed 2 February 2012).
2. Kent TS, Sachs TE, Callery MP, Vollmer CM. (2011) Readmission after
major pancreatic resection: a necessary evil? J Am Coll Surg 213:
515–523.
3. Yermilov I, Bentrem D, Sekeris E, Jain S, Maggard MA, Ko CY et al. (2009)
Readmissions following pancreaticoduodenectomy for pancreas cancer:
a population-based appraisal. Ann Surg Oncol 16:554–561.
4. Reddy DM, Townsend CM, Kou YF, Freeman JL, Goodwin JS, Riall TS.
(2009) Readmission after pancreatectomy for pancreatic cancer in Medi-
care patients. J Gastrointest Surg 13:1963–1974.
5. Grewal SS, McClaine RJ, Schmulewitz N, Alzahrani MA, Hanseman DJ,
Sussman JJ et al. (2011) Factors associated with recidivism following
pancreaticoduodenectomy. HPB 13:869–875.
6. Yeo CJ, Cameron JL, Sohn TA, Lillimoe KD, Pitt HA, Talamini MA et al.
(1997) Six hundred fifty consecutive pancreaticoduodenectomies in
the 1990s: pathology, complications, and outcomes. Ann Surg 226:248–
257.
7. Pecorelli N, Balzano G, Capretti G, Zerbi A, Di Caprio V, Braga M. (2011)
Effect of surgeon volume on outcome following pancreaticoduodenec-
tomy in a high-volume hospital. J Gastrointest Surg 16:518–523.
8. Riall TS, Cameron JL, Lillimoe KD, Campbell KA, Sauter PK, Coleman J
et al. (2005) Pancreaticoduodenectomy with or without distal gastrec-
tomy and extended retroperitoneal lymphadenectomy for periampullary
adenocarcinoma – part 3: update on 5-year survival. J Gastrointest Surg
9:1191–1204.
9. Brown RE, Qadan M, Martin RC, Polk HC. (2010) The evolving impor-
tance of readmission data to the practicing surgeon. J Am Coll Surg
211:558–560.
10. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J et al. (2005)
Postoperative pancreatic fistula: an international study group (ISGPF)
definition. Surgery 138:8–13.
11. Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR et al.
(2007) Delayed gastric emptying (DGE) after pancreatic surgery: a sug-
gested definition by the International Study Group of Pancreatic Surgery
(ISGPS). Surgery 142:761–768.
12. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. (1992) CDC
definitions of nosocomial surgical site infections, 1992: a modification of
CDC definitions of surgical wound infections. Infect Control Hosp Epide-
miol 13:606–608.
13. Emick DM, Riall TS, Cameron JL, Winter JM, Lillimoe KD, Coleman J
et al. (2006) Hospital readmission after pancreaticoduodenectomy.
J Gastrointest Surg 10:1243–1252.
14. Martin RC, Brown R, Puffer L, Block S, Callender G, Quillo A et al. (2011)
Readmission rates after abdominal surgery: the role of surgeon, primary
caregiver, home health, and subacute rehab. Ann Surg 254:591–597.
15. Jencks SF, Williams MV, Coleman EA. (2009) Rehospitalizations among
patients in the Medicare fee-for-service program. N Engl J Med 360:
1418–1428.
148 HPB
HPB 2013, 15, 142–148 © 2012 International Hepato-Pancreato-Biliary Association
